Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers is a research paper published in Acta Neuropathologica (2017). On theSindex it has a DataRank of 0.829. It has been cited 251 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.829
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute on Aging
Grant: R01AG044546
National Institute on Aging
Grant: RF1AG053303
National Institute on Aging
Grant: P01AG003991
NIA NIH HHS
Grant: P01 AG026276
NIA NIH HHS
Grant: P30 AG010124
NIDA NIH HHS
Grant: R25 DA027995
NIA NIH HHS
Grant: U24 AG021886
NIA NIH HHS
Grant: R01 AG035083
NIA NIH HHS
Grant: R03 AG050856
NIA NIH HHS
Grant: U01 AG032984
NIA NIH HHS
Grant: RF1 AG044546
NIA NIH HHS
Grant: U24 AG041689
NIA NIH HHS
Grant: P30 AG013846
NINDS NIH HHS
Grant: R01 NS085419
NIA NIH HHS
Grant: U01 AG024904
NIA NIH HHS
Grant: P50 AG005136
NIA NIH HHS
Grant: P50 AG005681
NIA NIH HHS
Grant: R01 AG054060
NIA NIH HHS
Grant: RF1 AG015473
NIH HHS
Grant: S10 OD018522
NIA NIH HHS
Grant: U01 AG016976
NIA NIH HHS
Grant: P30 AG010133
NIA NIH HHS
Grant: R01 AG015473
NLM NIH HHS
Grant: R01 LM012535
NIA NIH HHS
Grant: R01 AG019771
NIA NIH HHS
Grant: R01 AG048015
NIA NIH HHS
Grant: RF1 AG054023
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 5R01AG044546-03
IDENTIFYING RARE VARIANTS THAT INCREASE RISK FOR ALZHEIMER'S DISEASE
National Institutes of Health
Grant: 5P50AG005681-19
Role of LRP &its ligand tPA in LTP &aging
National Institutes of Health
Grant: 5U01AG016976-03
ALZHEIMERS DISEASE DATA COORDINATING CENTER
Wellcome Trust
Grant: 082604
A Powerful, Genome-Wide Association Scan for Susceptibility Genes for late-onset Alzheimer's disease
National Institutes of Health
Grant: 3P30AG010124-28S1
Alzheimer's Disease Core Center - Neuroimaging Core I
National Institutes of Health
Grant: 5R01AG048015-04
Identifying, validating and targeting AD susceptibility networks in monocytes
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5P01AG003991-38
Healthy Aging and Senile Dementia
National Institutes of Health
Grant: 5U24AG021886-18
National Cell Repository for Alzheimer's Disease (NCRAD)
National Institutes of Health
Grant: 7R01AG035083-06
Use of Endophenotypes in the Search for Alzheimer's Disease Risk Genes
National Institutes of Health
Grant: 5R01NS085419-04
Genetic Architecture of Acute Human Brain Ischemia
National Institutes of Health
Grant: 3RF1AG053303-01S1
USING QUANTITATIVE TRAITS TO IDENTIFY NOVEL GENES FOR ALZHEIMERS DISEASE AND OTHER COMPLEX TRAITS
National Institutes of Health
Grant: 5P01AG026276-07
Antecedent Neuroimaging Biomarkers
National Institutes of Health
Grant: 2R01AG019771-06
Memory Circuitry in MCI and Early Alzheimers Disease
National Institutes of Health
Grant: 5U01AG032984-15
Alzheimer's Disease Genetics Consortium
National Institutes of Health
Grant: 5U24AG041689-07
THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE
National Institutes of Health
Grant: 7R03AG050856-03
Novel Strategies for Blood-based Biomarkers for AD: Role of Genetic Variation in a Multivariate Framework
National Institutes of Health
Grant: 5P30AG010133-08
CORE-- EDUCATION AND INFORMATION TRANSFER
Wellcome Trust
Wellcome Trust
FWCI
17.23
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Workflow for Computational Design of p53 Stabilizers
Listed top candidate compounds with excellent docking scores
Molecular Dynamics Simulation Results for a Destabilizing Mutation
Results from Key Computational Case Studies
Summary of Key Computational Tools for nsSNP Analysis
The Integrated Computational Pipeline for nsSNP Analysis
The Protein Folding Energy
The Protein Misfolding Mechanism
Преодоление разрыва между генотипом и фенотипом: интеграция полногеномных ассоциативных исследований и вычислительной структурной биологии для расшифровки механизмов неправильного фолдинга белков, вызванного однонуклеотидными полиморфизмами, при заболеваниях человека
Additional file 1 of Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
Additional file 1 of Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
Additional file 1 of Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Additional file 1 of Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Additional file 2 of Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Additional file 2 of Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Additional file 2 of Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Additional file 2 of Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Additional file 1 of Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
Additional file 1 of Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
Additional file 1 of Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease